Beijing Hotgen Biotech (SHA:688068) recently obtained 35 overseas qualification certifications, according to a Tuesday filing with the Shanghai bourse.
These certifications cover a range of diagnostic reagents and equipment as well as biochemical tests mainly in the European Union, Indonesia and Cambodia.
Shares of the in vitro diagnostic device manufacturer closed 3% lower Tuesday.